Premature atherosclerosis in systemic lupus erythematosus

Rheumatic Disease Clinics of North America

Volumn 31, Issue 2, 2005, Pages 329-354

  Nikpour, Mandana ^a   Urowitz, Murray B ^a,b   Gladman, Dafna D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIMALARIAL AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FOLIC ACID; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; PHOSPHOLIPID ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOCARDIOGRAPHY; ATHEROGENESIS; AUTOPSY; B SCAN; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; EPIDEMIOLOGICAL DATA; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INCIDENCE; PERIPHERAL VASCULAR DISEASE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SCINTIGRAPHY; SCREENING; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ARTERIOSCLEROSIS; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; RISK FACTORS;

EID: 19544382185     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.01.001     Document Type: Review

References (108)

1. M. Abu-Shakra, M.B. Urowitz, D.D. Gladman, and J. Gough Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death J Rheumatol 22 7 1995 1259 1264
2. C. Aravanis, P. Toutouzas, and I. Yatzidis Fatal myocardial infarction in lupus erythematosus. Report of a case of a young female patient Vasc Dis 1 5 1964 258 260
3. M.B. Urowitz, A.A. Bookman, and B.E. Koehler The bimodal mortality pattern of systemic lupus erythematosus Am J Med 60 2 1976 221 225
4. C.J. Homcy, R.R. Liberthson, and J.T. Fallon Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases Am J Cardiol 49 2 1982 478 484
5. S. Fukumoto, T. Tsumagari, M. Kinjo, and K. Tanaka Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy Acta Pathol Jpn 37 1 1987 1 9
6. L.A. Rubin, M.B. Urowitz, and D.D. Gladman Mortality in systemic lupus erythematosus: the bimodal pattern revisited Q J Med 55 216 1985 87 98
7. D.D. Gladman, and M.B. Urowitz Morbidity in systemic lupus erythematosus J Rheumatol 14 13 Suppl 1987 223 226
8. S. Manzi, E.N. Meilahn, and J.E. Rairie Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study Am J Epidemiol 145 5 1997 408 415
9. M. Petri, S. Perez-Gutthann, D. Spence, and M.C. Hochberg Risk factors for coronary artery disease in patients with systemic lupus erythematosus Am J Med 93 5 1992 513 519
10. M.M. Ward Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus Arthritis Rheum 42 2 1999 338 346
11. M.M. Kaarisalo, P. Immonen-Raiha, and R.J. Marttila The risk of stroke following coronary revascularization-a population-based long-term follow-up study Scand Cardiovasc J 36 4 2002 231 236
12. R.J. Adams, M.I. Chimowitz, and J.S. Alpert Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association Stroke 34 9 2003 2310 2322
13. M.B. Urowitz, D.D. Gladman, and D. Ibanez Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors [abstract 1570] Arthritis Rheum 50 9 Suppl 2004 S594
14. P.G. Vlachoyiannopoulos, P.G. Kanellopoulos, and J.P. Ioannidis Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study Rheumatology (Oxford) 42 5 2003 645 651
15. S. Manzi, F. Selzer, and K. Sutton-Tyrrell Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus Arthritis Rheum 42 1 1999 51 60
16. M.J. Roman, J.E. Salmon, and R. Sobel Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome Am J Cardiol 87 5 2001 663 666
17. M.J. Roman, B.A. Shanker, and A. Davis Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus N Engl J Med 349 25 2003 2399 2406
18. J. McDonald, J. Stewart, M.B. Urowitz, and D.D. Gladman Peripheral vascular disease in patients with systemic lupus erythematosus Ann Rheum Dis 51 1 1992 56 60
19. E. Cosson, F. Paycha, and P. Tellier Lower-limb vascularization in diabetic patients. Assessment by thallium-201 scanning coupled with exercise myocardial scintigraphy Diabetes Care 24 5 2001 870 874
20. H.B. Hsu, S.S. Sun, and J.J. Chen Usefulness of thallium-201 muscle scan to investigate perfusion reserve in the lower limbs of patients with systemic lupus erythematosus Rheumatol Int 24 5 2004 291 293
21. C.C. Lin, H.J. Ding, and Y.W. Chen High prevalence of asymptomatically poor muscle perfusion of lower extremities measured in systemic lupus erythematosus patients with abnormal myocardial perfusion Rheumatol Int 24 4 2004 227 229
22. B.H. Bulkley, and W.C. Roberts The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients Am J Med 58 2 1975 243 264
23. G.L. Burke, G.W. Evans, and W.A. Riley Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Stroke 26 3 1995 386 391
24. F. Selzer, K. Sutton-Tyrrell, and S.G. Fitzgerald Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus Arthritis Rheum 50 1 2004 151 159
25. A. Doria, Y. Shoenfeld, and R. Wu Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus Ann Rheum Dis 62 11 2003 1071 1077
26. G. Belcaro, A. Barsotti, and A.N. Nicolaides Ultrasonic biopsy-a non-invasive screening technique to evaluate the cardiovascular risk and to follow up the progression and the regression of arteriosclerosis Vasa 20 1 1991 40 50
27. T. Wolak, E. Todosoui, and G. Szendro Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study J Rheumatol 31 5 2004 909 914
28. J.D. Hosenpud, A. Montanaro, and M.V. Hart Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus Am J Med 77 2 1984 286 292
29. I.N. Bruce, R.J. Burns, D.D. Gladman, and M.B. Urowitz Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities J Rheumatol 27 10 2000 2372 2377
30. D.S. Berman, H. Kiat, and J.D. Friedman Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study J Am Coll Cardiol 22 5 1993 1455 1464
31. E.M. Sella, E.I. Sato, and A. Barbieri Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy Arthritis Rheum 48 11 2003 3168 3175
32. B.K. Nallamothu, S. Saint, and L.F. Bielak Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis Arch Intern Med 161 6 2001 833 838
33. Y. Arad, L.A. Spadaro, and K. Goodman Prediction of coronary events with electron beam computed tomography J Am Coll Cardiol 36 4 2000 1253 1260
34. P.C. Keelan, L.F. Bielak, and K. Ashai Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography Circulation 104 4 2001 412 417
35. Y. Asanuma, A. Oeser, and A.K. Shintani Premature coronary-artery atherosclerosis in systemic lupus erythematosus N Engl J Med 349 25 2003 2407 2415
36. P.W. Wilson, W.P. Castelli, and W.B. Kannel Coronary risk prediction in adults (the Framingham Heart Study) Am J Cardiol 59 14 1987 91G 94G
37. P.W. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 18 1998 1837 1847
38. P. Rahman, M.B. Urowitz, and D.D. Gladman Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus J Rheumatol 26 11 1999 2363 2368
39. J.M. Esdaile, M. Abrahamowicz, and T. Grodzicky Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus Arthritis Rheum 44 10 2001 2331 2337
40. D.D. Gladman Epidemiology of systemic lupus erythematosus R.G. Lahita Systemic lupus erythematosus 4th edition 2004 Elsevier Academic Press San Diego (CA) 697 709
41. I.N. Bruce, D.D. Gladman, D. Ibanez, and M.B. Urowitz Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities J Rheumatol 30 2 2003 288 291
42. I.N. Bruce, M.B. Urowitz, D.D. Gladman, and D.C. Hallett Natural history of hypercholesterolemia in systemic lupus erythematosus J Rheumatol 26 10 1999 2137 2143
43. E.F. Borba, and E. Bonfa Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies Lupus 6 6 1997 533 539
44. I.N. Bruce, M.B. Urowitz, and D.D. Gladman Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study Arthritis Rheum 48 11 2003 3159 3167
45. D. Ibanez, M.B. Urowitz, and D.D. Gladman Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus J Rheumatol 30 9 2003 1977 1982
46. D.D. Gladman, D. Ibanez, and M.B. Urowitz Systemic lupus erythematosus disease activity index 2000 J Rheumatol 29 2 2002 288 291
47. D. Ibanez, D.D. Gladman, and M.B. Urowitz Adjusted Mean SLEDAI-2K (AMS) in Outcome Prediction in SLE [Abstract 400] Arthritis Rheum 50 9 Suppl 2004 S199
48. J.C. Tsai, M.A. Perrella, and M. Yoshizumi Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis Proc Natl Acad Sci USA 91 14 1994 6369 6373
49. A.G. Bostom, I.H. Rosenberg, and H. Silbershatz Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study Ann Intern Med 131 5 1999 352 355
50. M.J. Stampfer, M.R. Malinow, and W.C. Willett A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians JAMA 268 7 1992 877 881
51. M. Petri, R. Roubenoff, and G.E. Dallal Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus Lancet 348 9035 1996 1120 1124
52. G.L. Booth, and E.E. Wang Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care CMAJ 163 1 2000 21 29
53. P.M. Ridker, M. Cushman, and M.J. Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 14 1997 973 979
54. P.M. Ridker, J.E. Buring, and J. Shih Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 8 1998 731 733
55. F. Selzer, K. Sutton-Tyrrell, and S. Fitzgerald Vascular stiffness in women with systemic lupus erythematosus Hypertension 37 4 2001 1075 1082
56. S.A. Hope, and I.T. Meredith Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis Intern Med J 33 8 2003 380 386
57. P.M. Ridker, C.H. Hennekens, and B. Roitman-Johnson Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men Lancet 351 9096 1998 88 92
58. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 12 2000 836 843
59. K. Peter, P. Nawroth, and C. Conradt Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin Arterioscler Thromb Vasc Biol 17 3 1997 505 512
60. U. Schonbeck, N. Varo, and P. Libby Soluble CD40L and cardiovascular risk in women Circulation 104 19 2001 2266 2268
61. D. Carvalho, C.O. Savage, D. Isenberg, and J.D. Pearson IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner Arthritis Rheum 42 4 1999 631 640
62. N. Del Papa, G. Conforti, and D. Gambini Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis Clin Immunol Immunopathol 70 3 1994 211 216
63. Z.A. Yazici, E. Raschi, and A. Patel Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro Int Immunol 13 3 2001 349 357
64. W.H. Ettinger Jr, and W.R. Hazzard Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus J Clin Endocrinol Metab 67 3 1988 425 428
65. G. Walldius, and I. Jungner Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy J Intern Med 255 2 2004 188 205
66. M. Abu-Shakra, D.D. Gladman, M.B. Urowitz, and V. Farewell Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations Am J Med 99 6 1995 624 628
67. S.R. Levine, L. Salowich-Palm, and K.L. Sawaya IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study Stroke 28 9 1997 1660 1665
68. Y. Maaravi, E. Raz, D. Gilon, and A. Rubinow Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus Ann Rheum Dis 48 10 1989 853 855
69. E. Zuckerman, E. Toubi, and A. Shiran Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study Am J Med 101 4 1996 381 386
70. O. Vaarala Antiphospholipid antibodies and myocardial infarction Lupus 7 Suppl 2 1998 S132 S134
71. R. Wu, S. Nityanand, and L. Berglund Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction Arterioscler Thromb Vasc Biol 17 11 1997 3159 3163
72. A. Farsi, M.P. Domeneghetti, and S. Fedi High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease Autoimmunity 30 2 1999 93 98
73. P. Fiallo, C. Tomasina, A. Clapasson, and P.P. Cardo Antibodies to beta(2)-glycoprotein I in ischemic stroke Cerebrovasc Dis 10 4 2000 293 297
74. D. Tanne, D.A. Triplett, and S.R. Levine Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more Stroke 29 9 1998 1755 1758
75. N. Kattwinkel, A.G. Villanueva, and S.B. Labib Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome Ann Intern Med 116 12 Pt 1 1992 974 976
76. J.J. Murphy, and I.H. Leach Findings at necropsy in the heart of a patient with anticardiolipin syndrome Br Heart J 62 1 1989 61 64
77. A. Rangel, C. Lavalle, and E. Chavez Myocardial infarction in patients with systemic lupus erythematosus with normal findings from coronary arteriography and without coronary vasculitis-case reports Angiology 50 3 1999 245 253
78. Y. Sherer, and Y. Shoenfeld Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Immunobiology 207 1 2003 13 16
79. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 2 1999 115 126
80. A.M. Zeiher, H. Drexler, H. Wollschlager, and H. Just Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis Circulation 84 5 1991 1984 1992
81. M.C. Corretti, G.D. Plotnick, and R.A. Vogel Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound Am J Physiol 268 4 Pt 2 1995 H1397 H1404
82. M.C. Corretti, T.J. Anderson, and E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2 2002 257 265
83. T.J. Anderson, A. Uehata, and M.D. Gerhard Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 26 5 1995 1235 1241
84. K.L. Hardie, S. Kinlay, and D.B. Hardy Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial function Aust N Z J Med 27 6 1997 649 652
85. D.S. Lima, E.I. Sato, and V.C. Lima Brachial endothelial function is impaired in patients with systemic lupus erythematosus J Rheumatol 29 2 2002 292 297
86. M. El-Magadmi, H. Bodill, and Y. Ahmad Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women Circulation 110 4 2004 399 404
87. M. Nikpour, M.B. Urowitz, and D.D. Gladman Prevalence and risk factors for endothelial dysfunction in systemic lupus erythematosus [Abstract F39] Arthritis Rheum 50 12 2004 4093 4094
88. M. Nikpour, M.B. Urowitz, and D.D. Gladman Relationship between myocardial perfusion scintigraphy and brachial artery endothelial function in systemic lupus erythematosus [Abstract F27] Arthritis Rheum 50 12 2004 4089 4090
89. D.H. O'Leary, J.F. Polak, and R.A. Kronmal Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 1 1999 14 22
90. I.M. van der Meer, M.L. Bots, and A. Hofman Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study Circulation 109 9 2004 1089 1094
91. M. Nikpour, M.B. Urowitz, and D.D. Gladman Relationship Between scintigraphic myocardial perfusion defects and coronary angiographic findings in patients with SLE [Abstract F28] Arthritis Rheum 50 12 2004 4090
92. G.B. Mancini Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease Am J Med 105 1A 1998 40S 47S
93. M.G. Modena, L. Bonetti, and F. Coppi Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women J Am Coll Cardiol 40 3 2002 505 510
94. M.B. Urowitz, D.D. Gladman, and D. Ibanez Atherosclerotic vascular events in a risk factor study from a single center: prevalence and risk factors [Abstract 1569] Arthritis Rheum 50 9 Suppl 2004 S594
95. I.N. Bruce, D.D. Gladman, and M.B. Urowitz Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study Clin Exp Rheumatol 16 4 1998 435 440
96. M. Petri, D. Spence, L.R. Bone, and M.C. Hochberg Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices Medicine (Baltimore) 71 5 1992 291 302
97. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report Circulation 106 25 2002 3143 3421
98. E.F. Borba, and E. Bonfa Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy J Rheumatol 28 4 2001 780 785
99. H.N. Hodis, F.P. Quismorio Jr, E. Wickham, and D.H. Blankenhorn The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus J Rheumatol 20 4 1993 661 665
100. P. Rahman, D.D. Gladman, and M.B. Urowitz The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs J Rheumatol 26 2 1999 325 330
101. L.S. Tam, D.D. Gladman, and D.C. Hallett Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus J Rheumatol 27 9 2000 2142 2145
102. D.J. Wallace, M. Linker-Israeli, A.L. Metzger, and V.J. Stecher The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE Lupus 2 1 Suppl 1993 S13 S15
103. J.T. Kuvin, and R.H. Karas Clinical utility of endothelial function testing: ready for prime time? Circulation 107 25 2003 3243 3247
104. S. Tsiara, M. Elisaf, and D.P. Mikhailidis Early vascular benefits of statin therapy Curr Med Res Opin 19 6 2003 540 556
105. N. Hosomi, K. Mizushige, and H. Ohyama Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus Stroke 32 7 2001 1539 1545
106. H. Koshiyama, S. Tanaka, and J. Minamikawa Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes J Cardiovasc Pharmacol 33 6 1999 894 896
107. M. Rajzer, M. Klocek, and K. Kawecka-Jaszcz Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension Am J Hypertens 16 6 2003 439 444
108. A.V. Stanton, J.N. Chapman, and J. Mayet Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery Clin Sci (Lond) 101 5 2001 455 464